Literature DB >> 17321870

Endolymphatic mastoid shunt versus endolymphatic sac decompression for Ménière's disease.

George M Brinson1, Douglas A Chen, Moisés A Arriaga.   

Abstract

OBJECTIVE: This study compares the efficacy of endolymphatic mastoid shunt (EMS) versus endolymphatic sac decompression (ESD) without sac incision for the treatment of Ménière's disease. STUDY DESIGN AND
SETTING: The AAO-HNS Guidelines for the Diagnosis and Evaluation of Therapy in Ménière's disease were used to retrospectively identify suitable candidates for the study. All patients who failed medical management and underwent either endolymphatic-mastoid shunt (EMS) (n = 88) or endolymphatic sac decompression (ESD) (n = 108) were selected for review using the AAO-HNS guidelines. The study was carried out at a tertiary care neurotology private practice.
RESULTS: EMS and ESD were equally effective in reducing the incidence and severity of vertigo attacks with significant improvement in 67 percent and 66 percent of patients, respectively.
CONCLUSION: Both EMS and ESD are effective, nondestructive alternatives for patients who have failed medical management of Ménière's disease with similar long-term hearing outcomes. SIGNIFICANCE: This is the only study within the same institution using AAO-HNS guidelines comparing EMS versus ESD.

Entities:  

Mesh:

Year:  2007        PMID: 17321870     DOI: 10.1016/j.otohns.2006.08.031

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  16 in total

Review 1.  Current evidence for endolymphatic sac surgery in the treatment of Meniere's disease: a systematic review.

Authors:  Ming Yann Lim; Margaret Zhang; Heng Wai Yuen; Jern-Lin Leong
Journal:  Singapore Med J       Date:  2015-11       Impact factor: 1.858

2.  Preclinical and clinical studies of unrelieved aural fullness following intratympanic gentamicin injection in patients with intractable Ménière's disease.

Authors:  Feng Zhai; Ru Zhang; Ting Zhang; Peter S Steyger; Chun-Fu Dai
Journal:  Audiol Neurootol       Date:  2013-08-30       Impact factor: 1.854

3.  [Indications for operative therapy of vestibular vertigo and the associated success rates].

Authors:  M Westhofen
Journal:  HNO       Date:  2013-09       Impact factor: 1.284

Review 4.  [Surgical therapy in Menière's disease. Historical development and today's state of the art].

Authors:  G Baier; I Ott
Journal:  HNO       Date:  2008-05       Impact factor: 1.284

5.  Treatment of Menière's Disease.

Authors:  Jeffrey D Sharon; Carolina Trevino; Michael C Schubert; John P Carey
Journal:  Curr Treat Options Neurol       Date:  2015-04       Impact factor: 3.598

6.  Vestibular and audiometric results after endolymphatic mastoid shunt surgery in patients with Menière's disease.

Authors:  Jennifer L Spiegel; Ivelina Stoycheva; Bernhard G Weiss; Mattis Bertlich; Tobias Rader; Martin Canis; Friedrich Ihler
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-08-15       Impact factor: 3.236

7.  Is endolymphatic sac surgery an efficient treatment of Menière's disease patients? A systematic literature search and meta-analysis.

Authors:  Franziska A Szott; M Westhofen; S Hackenberg
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-10-08       Impact factor: 3.236

8.  Endolymphatic sac surgery versus tenotomy of the stapedius and tensor tympani muscles in the management of patients with unilateral definite Meniere's disease.

Authors:  Silviu Albu; Gregorio Babighian; Maurizio Amadori; Franco Trabalzini
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-12-07       Impact factor: 2.503

Review 9.  [Menière's disease : evidence and controversies].

Authors:  M Westhofen
Journal:  HNO       Date:  2009-05       Impact factor: 1.284

10.  Impact of endolymphatic mastoid shunt surgery on saccule and lateral semicircular canal function.

Authors:  Jonas Jae-Hyun Park; Yue-Shih Chen; Martin Westhofen
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-01       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.